Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines



   hypertonia
  

Disease ID 1830
Disease hypertonia
Definition
Abnormal increase in skeletal or smooth muscle tone. Skeletal muscle hypertonicity may be associated with PYRAMIDAL TRACT lesions or BASAL GANGLIA DISEASES.
Synonym
high muscle tone
high muscles tone
hypermyotonia
hypermyotonias
hypertonia, muscle
hypertonia, nos
hypertonias, muscle
hypertonicities, muscular
hypertonicity
hypertonicity, muscular
hypertonus
increased muscle tone
increased muscle tone (finding)
increased tone
increased, muscle tone
muscle hypertonia
muscle hypertonia [disease/finding]
muscle hypertonias
muscle hypertonicity
muscle tight
muscle tone increased
muscles tight
muscular hypertonicities
muscular hypertonicity
muscular hypertonicity (disorder)
muscular hypertonus
muscular tone excessive
muscular tone increased
scottie cramp
tight muscle
tone increased, muscle
UMLS
C0026826
MeSH
SNOMED-CT
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:12)
C0007789  |  cerebral palsy  |  4
C0026848  |  myopathy  |  1
C0004096  |  asthma  |  1
C0025362  |  mental retardation  |  1
C0030567  |  parkinson's disease  |  1
C0004096  |  bronchial asthma  |  1
C0206157  |  nemaline myopathy  |  1
C0018991  |  hemiplegia  |  1
C0037928  |  myelopathy  |  1
C0032914  |  preeclampsia  |  1
C0034372  |  quadriplegia  |  1
C0013421  |  dystonia  |  1
Curated Gene
Entrez_id | Symbol | Resource(Total Genes:1)
OXT  |  5020  |  CTD_human
Inferring Gene(Waiting for update.)
Text Mined Gene(Waiting for update.)
Locus(Waiting for update.)
Disease ID 1830
Disease hypertonia
Integrated Phenotype(Waiting for update.)
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:26)
HP:0100021  |  Cerebral palsy  |  4
HP:0001252  |  Hypotonia  |  3
HP:0002063  |  Muscle rigidity  |  3
HP:0001263  |  Developmental retardation  |  2
HP:0008936  |  Truncal hypotonia  |  2
HP:0002459  |  Dysautonomia  |  2
HP:0002104  |  Absence of spontaneous respiration  |  2
HP:0100602  |  Pre-eclampsia  |  1
HP:0001249  |  Mental retardation  |  1
HP:0001270  |  Motor retardation  |  1
HP:0001297  |  Cerebral vascular events  |  1
HP:0002445  |  Paralysis of all four limbs  |  1
HP:0002301  |  Hemiplegia  |  1
HP:0001336  |  Myoclonic jerks  |  1
HP:0003198  |  Myopathic changes  |  1
HP:0002396  |  Cogwheel rigidity  |  1
HP:0001332  |  Dystonia  |  1
HP:0001662  |  Bradycardia  |  1
HP:0000961  |  Cyanosis  |  1
HP:0006801  |  Brisk deep tendon reflexes  |  1
HP:0012390  |  Anal fissure  |  1
HP:0007185  |  Loss of consciousness  |  1
HP:0002067  |  Bradykinesia  |  1
HP:0001269  |  Hemiparesis  |  1
HP:0002099  |  Asthma  |  1
HP:0002196  |  Myelopathy  |  1
Disease ID 1830
Disease hypertonia
Manually Symptom(Waiting for update.)
Text Mined Symptom(Waiting for update.)
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:1)
snpId pubmedId geneId geneSymbol diseaseId sourceId sentence score Year geneSymbol_dbSNP CHROMOSOME POS REF ALT
rs80338792239587736329SCN4Aumls:C0026826BeFreeThe diagnostic sequence in both patients was the same: first, severe episodic apneic attacks necessitating hospitalization occurring in the first week of life; second, observation of muscle hypertrophy and peripheral hypertonia with a clear myotonic pattern on electromyogram (at 14 and 3 months of age, respectively); third, genetic testing revealing de novo SCN4A G1306E mutation.0.0002714422013SCN4A1763943846CT,G,A
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:0)
(Waiting for update.)
Mapped by lexical matching(Total Items:0)
(Waiting for update.)
Mapped by homologous gene(Total Items:0)
(Waiting for update.)
Chemical(Total Drugs:12)
CUI ChemicalName ChemicalID CasRN DiseaseName DiseaseID DirectEvidence PubMedIDs
C0026826amitriptylineD00063950-48-6muscle hypertoniaMESH:D009122marker/mechanism7775702
C0026826baclofenD0014181134-47-0muscle hypertoniaMESH:D009122therapeutic4266642
C0026826droperidolD004329548-73-2muscle hypertoniaMESH:D009122marker/mechanism12378031
C0026826enalaprilD00465675847-73-3muscle hypertoniaMESH:D009122marker/mechanism2404862
C0026826haloperidolD00622052-86-8muscle hypertoniaMESH:D009122marker/mechanism10847307
C0026826mifepristoneD01573584371-65-3muscle hypertoniaMESH:D009122marker/mechanism11435005
C0026826morphineD00902057-27-2muscle hypertoniaMESH:D009122marker/mechanism6110016
C0026826olanzapineC076029132539-06-1muscle hypertoniaMESH:D009122marker/mechanism10847307
C0026826phenytoinD01067257-41-0muscle hypertoniaMESH:D009122marker/mechanism3994321
C0026826prochlorperazineD01134658-38-8muscle hypertoniaMESH:D009122marker/mechanism216517
C0026826succinylcholineD013390306-40-1muscle hypertoniaMESH:D009122marker/mechanism7171420
C0026826sulpirideD01346915676-16-1muscle hypertoniaMESH:D009122marker/mechanism6110016
FDA approved drug and dosage information(Total Drugs:0)
(Waiting for update.)
FDA labeling changes(Total Drugs:0)
(Waiting for update.)